Investors & Media

InBriefs

InBriefs

May 6, 2020
Lancet Neurology: Teens and adults on SPINRAZA® showed clinically meaningful improvement in motor function
March 30, 2020
Ionis Statement on COVID-19
February 27, 2020
Ionis and partner highlight tominersen (formerly known as IONIS-HTTRx and RG6042) data at annual Huntington’s disease drug discovery conference